Life sciences in transition : challenges of omics technologies for Germany's infrastructures in research and teaching / publisher: Deutsche Akademie der Naturforscher Leopoldina e.V. - German National Academy of Sciences ; editors: Dr. Constanze Breuer, Dr. Johannes Fritsch
Anzeigen / Download2.85 MB
Discovery
1814582398
URN
urn:nbn:de:gbv:3:2-903697
DOI
ISBN
ISSN
Autorin / Autor
Beiträger
Körperschaft
Erschienen
Halle (Saale), Germany : Deutsche Akademie der Naturforscher Leopoldina e.V. - German National Academy of Sciences, 2015
Umfang
1 Online-Ressource (37 Seiten, 2,84 MB)
Ausgabevermerk
1st edition
Sprache
eng
Anmerkungen
Auf der Homepage findet sich für diese Online-Ausgabe die ISBN der deutschsprachigen gedruckten Ausgabe
Inhaltliche Zusammenfassung
At the start of the 21st century, life sciences are undergoing a radical change. Groundbreaking technologies are opening up entirely new possibilities of analysing life processes. Using omics technologies, different biomolecules, for example DNA, RNA, proteins or metabolites, can be detected in living organisms almost in their totality. Based on omics data, life sciences such as molecular biology, biomedicine or health research increasingly aim to obtain a computer-assisted observation of molecular processes and thereby a new understanding of life processes. The new technologies generate huge quantities of data of which only fragments can be analysed at present. This generates the so-called Big Data problem as the surge in data quantities does not automatically mean a greater knowledge acquisition. The challenge is to extract and analyse information from the wealth of digital data that is relevant to the respective scientific issue. Moreover, the data and the findings derived from this data need to be made available to the scientific community using suitable networks requiring close interdisciplinary collaboration between life sciences and other scientific fields such as informatics, mathematics, physics and engineering. This Report on Tomorrow’s Science presents a clear diagnosis: Germany is not adequately prepared for the rapid developments in omics technologies, particularly the information technology requirements of these technologies.